Method‐of‐use study of naltrexone sustained release (<scp>SR</scp>)/bupropion <scp>SR</scp> on body weight in individuals with obesity

Abstract

Treatment with NB, used as indicated by prescribing information and with CLI, significantly improved weight loss over usual care alone. NB-facilitated weight loss was sustained for 78 weeks and was deemed safe and well tolerated.